ARTICLE

FindCenter AddIcon

Ketamine for Depression Still Too Expensive for Widespread Use

By Technology Networks — 2020

A paper authored by researchers from McLean Hospital has determined that esketamine, a nasal spray to treat severe depression, is currently too expensive for widespread use. The study compared the costs and benefits of esketamine, an antidepressant approved by the U.S. Food and Drug Administration (FDA) last year for use in treatment-resistant major depressive disorder.

Read on www.technologynetworks.com

FindCenter Post-Image

3 Ways Leaders Can Prevent Emotional Drain

When it comes to supporting employees to thrive despite the emotional fallout of the pandemic, leaders (and mindfulness) have a critical role to play.

FindCenter AddIcon
FindCenter Post-Image

Research Finds Self-Compassion Can Relieve Depression

A new study finds that self-compassion can lessen chronic depression.

FindCenter AddIcon

EXPLORE TOPIC

Clinical Depression